Abstract:BARF1, encoded by Epstein-Barr virus (EBV), has been hypothesized to function as an oncogene, which was expressed in gastric carcinoma cells. Additionally, it has been reported that the anti-apoptotic function is closely associated with the expression of the B-cell lymphoma-2 (Bcl-2) protein. In addition, the signaling pathway has been reported to be involved in numerous diseases, including the mitogen-activated protein kinase (MAPK) cascade. In order to study the specific mechanism of anti-apoptotic function, BARF1-stably-expressing immortalized normal human embryo gastric epithelial cell line GES1 (GES-BARF1), and well-, moderately- and poorly-differentiated gastric carcinoma cell lines, MKN28 (which has been reported to be contaminated with the moderately-differentiated MKN74 gastric carcinoma cell line), SGC7901 and BGC823 (MKN-BARF1, SGC-BARF1 and BGC-BARF1, respectively) (GCC-BARF1) were constructed, with transfection of cells with the empty vector pSG5 acting as controls. Western blot analysis was performed to analyze the protein expression and the phosphorylation levels. Compared with the controls, it was found that the protein expression levels of c-Jun, Bcl-2 and B-cell lymphoma-extra large (Bcl-xL), as well as the phosphorylation levels of c-Jun, c-Jun N-terminal kinase (JNK) 1/2/3, p38 and extracellular signal-regulated kinase (ERK) 1/2 proteins were upregulated in 3 GCC-BARF1 but not significantly changed in GES-BARF1. The expression levels of the c-Jun, Bcl-2 and Bcl-xL proteins, and levels of c-Jun protein phosphorylation were significantly decreased in SGC-BARF1 cells subsequent to treatment with SP600125, SB203580, and U0126, which were the specific inhibitors of JNK1/2/3, p38 and ERK1/2 respectively. In addition, there was a gradual increase in the protein expression and phosphorylation levels between normal gastric epithelial cells, and well-differentiated, moderately-differentiated and poorly-differentiated gastric carcinoma cells, but this was not statistically significant. Therefore, the present study hypothesized that JNK1/2/3-, p38- and ERK1/2-MAPK/c-Jun cascade signaling pathways may contribute to the upregulation of the expression of the anti-apoptotic proteins Bcl-2 and Bcl-xL induced by BARF1 in gastric carcinoma cells. This mechanism may mainly work in the progressive phase of the development in EBV-associated gastric carcinoma.

[G-Protein-coupled Muscarinic Acetylcholine Receptor Activation Up-Regulates Bcl-2 and Phospho-Bad Via Ras-ERK-1/2 Signaling Pathway].

Muscarinic Receptors Mediate Phospholipase C-dependent Activation of Protein Kinase B Via Ca2+, ErbB3, and Phosphoinositide 3-Kinase in 1321N1 Astrocytoma Cells.

Muscarinic Receptor-Mediated Activation of P70 S6 Kinase 1 (s6k1) in 1321n1 Astrocytoma Cells: Permissive Role of Phosphoinositide 3-Kinase

Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors

Down-Regulation of Bcl-2 Enhances Autophagy Activation and Cell Death Induced by Mitochondrial Dysfunction in Rat Striatum

Muscarinic acetylcholine receptor-mediated phosphorylation of extracellular signal-regulated kinase in HSY salivary ductal cells involves distinct signaling pathways

Arsenic trioxide promotes ERK1/2-mediated phosphorylation and degradation of BIMEL to attenuate apoptosis in BEAS-2B cells

Activation of Muscarinic Receptors Inhibits Glutamate-Induced GSK-3β Overactivation in PC12 Cells

Abstract LB-75: Glucocorticoid Receptor Activation Inhibits P53-Induced Apoptosis of MCF10A Myc Cells Via Induction of Protein Kinase C Epsilon

The Β 2 -Adrenergic Receptor Delivers an Antiapoptotic Signal to Cardiac Myocytes Through G I -Dependent Coupling to Phosphatidylinositol 3′-Kinase

Muscarinic Receptor Activation Increases Herg Channel Expression Through Phosphorylation of Ubiquitin Ligase Nedd4-2.

B1-induced Caspase-Independent Apoptosis in MCF-7 Cells is Mediated by Down-Regulation of Bcl-2 Via P53 Binding to P2 Promoter TATA Box

A CalDAG-GEFI/Rap1/B-Raf Cassette Couples M1Muscarinic Acetylcholine Receptors to the Activation of ERK1/2

Blocking M2 Muscarinic Receptor Signaling Inhibits Tumor Growth and Reverses Epithelial-Mesenchymal Transition (EMT) in Non-Small Cell Lung Cancer (NSCLC)

Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy

Resistance to BH3 mimetic S1 in SCLC cells that up-regulate and phosphorylate Bcl-2 through ERK1/2

Regulatory Effect BAD Protein to Cell Apoptosis

Bcl-2 Phosphorylation Required for Anti-apoptosis Function

Machrs Activation Induces Epithelial-Mesenchymal Transition on Lung Epithelial Cells

MAPK/c-Jun signaling pathway contributes to the upregulation of the anti-apoptotic proteins Bcl-2 and Bcl-xL induced by Epstein-Barr virus-encoded BARF1 in gastric carcinoma cells

ERK activation and cell growth require CaM kinases in MCF-7 breast cancer cells